| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.6× | −1.7× | |
| Price / Book | 0.6× | 2.0× | |
| Price / Sales | 1.5× | 4.0× | |
| Price / Free cash flow | −6.1× | −1.5× | |
| EV / EBITDA | −1.8× | −1.2× | |
| Earnings yield | −61.6% | −14.3% | |
| Free cash flow yield | −16.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,292.00 | +4.16% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.11 | +2.10% | $624.43B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.54 | +2.43% | $511.65B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.27 | +3.54% | $378.13B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.93 | +2.99% | $364.97B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.32 | +2.08% | $282.64B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.56 | +2.81% | $261.42B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $686.56 | +1.06% | $253.85B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.58 | +2.27% | $234.95B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.27 | +1.44% | $192.53B | 22.3× | 37.5% | +29.9% |
